Search research articles
Contact Us
Filters
Showing results (41-50 of 127) with videos related to
Page
of 13
Sort By:
Critical Reviews in Oncology/Hematology
|
November 8, 2017
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials
Sergio Rizzo, Antonio Galvano, Francesco Pantano, et al.
Oncotarget
|
February 27, 2016
PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis
Francesco Passiglia, Giuseppe Bronte, Viviana Bazan, et al.
Cancer Treatment Reviews
|
July 14, 2021
Repositioning PARP inhibitors in the treatment of thoracic malignancies
Francesco Passiglia, Maria Lucia Reale, Valeria Cetoretta, et al.
Expert Opinion on Biological Therapy
|
September 12, 2015
Prognostic and predictive biomarkers for targeted therapy in NSCLC: for whom the bell tolls?
Francesco Passiglia, Giuseppe Bronte, Marta Castiglia, et al.
Cancers
|
October 14, 2023
Exploring the Potential of Non-Coding RNAs as Liquid Biopsy Biomarkers for Lung Cancer Screening: A Literature Review
Edoardo Garbo, Benedetta Del Rio, Giorgia Ferrari, et al.
Expert Review of Anticancer Therapy
|
August 23, 2014
Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?
Christian Rolfo, Giovanni Sortino, Evelien Smits, et al.
Translational Cancer Research
|
February 4, 2022
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer
Angela Listì, Nadia Barraco, Marco Bono, et al.
Critical Reviews in Oncology/Hematology
|
January 22, 2022
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences
Stefano Fogli, Fabrizio Tabbò, Annalisa Capuano, et al.
Scientific Reports
|
September 8, 2018
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis
Francesco Passiglia, Sergio Rizzo, Massimo Di Maio, et al.
Current Cancer Drug Targets
|
March 10, 2018
Metastatic Site Location Influences the Diagnostic Accuracy of ctDNA EGFR- Mutation Testing in NSCLC Patients: a Pooled Analysis
Francesco Passiglia, Sergio Rizzo, Christian Rolfo, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 127) with videos related to
Sort By:
Page
of 13
Critical Reviews in Oncology/Hematology
|
November 8, 2017
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials
Sergio Rizzo, Antonio Galvano, Francesco Pantano, et al.
Oncotarget
|
February 27, 2016
PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis
Francesco Passiglia, Giuseppe Bronte, Viviana Bazan, et al.
Cancer Treatment Reviews
|
July 14, 2021
Repositioning PARP inhibitors in the treatment of thoracic malignancies
Francesco Passiglia, Maria Lucia Reale, Valeria Cetoretta, et al.
Expert Opinion on Biological Therapy
|
September 12, 2015
Prognostic and predictive biomarkers for targeted therapy in NSCLC: for whom the bell tolls?
Francesco Passiglia, Giuseppe Bronte, Marta Castiglia, et al.
Cancers
|
October 14, 2023
Exploring the Potential of Non-Coding RNAs as Liquid Biopsy Biomarkers for Lung Cancer Screening: A Literature Review
Edoardo Garbo, Benedetta Del Rio, Giorgia Ferrari, et al.
Expert Review of Anticancer Therapy
|
August 23, 2014
Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?
Christian Rolfo, Giovanni Sortino, Evelien Smits, et al.
Translational Cancer Research
|
February 4, 2022
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer
Angela Listì, Nadia Barraco, Marco Bono, et al.
Critical Reviews in Oncology/Hematology
|
January 22, 2022
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences
Stefano Fogli, Fabrizio Tabbò, Annalisa Capuano, et al.
Scientific Reports
|
September 8, 2018
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis
Francesco Passiglia, Sergio Rizzo, Massimo Di Maio, et al.
Current Cancer Drug Targets
|
March 10, 2018
Metastatic Site Location Influences the Diagnostic Accuracy of ctDNA EGFR- Mutation Testing in NSCLC Patients: a Pooled Analysis
Francesco Passiglia, Sergio Rizzo, Christian Rolfo, et al.
Page
of 13